Clinical Research
BibTex RIS Cite

ZAYIF VE OBEZ PCOS’ DA İNSÜLİN REZİSTANSI VE KAN BETATROFİN DÜZEYLERİ ARASINDAKİ İLİŞKİ

Year 2024, Volume: 21 Issue: 1, 39 - 46, 01.04.2024
https://doi.org/10.38136/jgon.1315838

Abstract

Amaç: Polikistik over sendromlu (PKOS) kadınların yaklaşık %70'inde insülin direnci ve buna bağlı metabolik bozukluklar vardır, ancak insülin direncine yol açan altta yatan mekanizma bilinmemektedir. Betatrofin, karaciğerde ve yağ dokusunda eksprese edilen ve insülin direnci ve β-hücre proliferasyonu ile ilişkili olduğu bulunan bir proteindir. Bu çalışmanın amacı, PKOS olgularında dolaşımdaki betatrofin düzeyini değerlendirmek ve obezite ve insülin direnci ile ilişkisini araştırmaktır.
Yöntemler: Bu prospektif kesitsel çalışmada, ELİSA test kitleri kullanılarak normo-ağırlıklı 35 tane PCOS vakasında ve 38 tane fazla kilolu/obez PCOS vakasında (BMI≥25) dolaşan betatrofin seviyeleri ölçüldü. Betatrofin seviyeleri, antropometrik ölçümler, açlık kan şekeri, glikoz yüklemesinden 2 saat sonra kan şekeri ve insülin direncinin homeostaz modeli değerlendirmesi (HOMA-IR) değerleri karşılaştırıldı.
Bulgular: Normal ağırlıklı PKOS grubunun dolaşımdaki betatrofin düzeyleri aşırı kilolu/obez PKOS grubuna göre anlamlı derecede yüksek bulundu (p=0,023). Betatrofin ve HOMA-IR seviyeleri arasında anlamlı bir ilişki yoktu.
Sonuç: Betatrofin, aşırı kilolu/obez grupta normo-ağırlıklı PKOS grubuna göre anlamlı derecede düşük bulundu. Betatrofinin PKOS ve insülin direncindeki rolü yeterince aydınlatılamadığından PKOS hastalarında insülin direncinin iyi bir öngörücüsü olmadığı söylenebilir.

Supporting Institution

yok

Project Number

yok

Thanks

yok

References

  • 1. Kahraman S, Altinova AE, Yalcin MM, Gulbahar O, Arslan B, Akturk M, Cakir N ,Toruner FB. Association of serum betat- rophin with fibroblast growth factor-21 in women with polycys- tic ovary syndrome. Journal of endocrinological investigation. 2018; 41(9), 1069-1074. 2. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz, R. Poly- cystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology. 2011; 7(4), 219-231. 3. Li L, Zhang F, Cui J, Shi Y, Xiang J, Wang X et al. Associa- tion of betatrophin with metabolic characteristics in overweight/ obese and lean women with PCOS. Gynecological Endocrino- logy. 2017; 33(3), 238-243.

THE RELATIONSHIP BETWEEN CIRCULATING BETATROPHIN LEVELS AND INSULIN RESISTANCE IN NORMO-WEIGHT AND OVERWEIGHT/OBESE PCOS

Year 2024, Volume: 21 Issue: 1, 39 - 46, 01.04.2024
https://doi.org/10.38136/jgon.1315838

Abstract

Objective: About 70% of women with polycystic ovary syndrome (PCOS) have insulin resistance and related metabolic disorders but the underlying mechanism leading to insulin resistance remain unknown. Betatrophin is a protein expressed in the liver and adipose tissue that has been found to be related to insulin resistance and β-cell proliferation. The aim of this study is evaluate the circulating betatrophin level in PCOS cases and to investigate its relationship with obesity and insulin resistance.

Methods: In this prospective cross-sectional study circulating betatrophin levels were measured in 35 PCOS cases with normo-weight and 38 overweight/ obese PCOS cases (BMI≥25) using spesific enzyme-linked immunosorbent assay kits. Betatrophin levels, antropometric measurements, fasting blood glucose, 2 -hour post-glucose load blood glucose and homeostasis model assessment of insulin resistance (HOMA-IR) values were compared.

Results: Circulating betatrophin levels of the normo-weight PCOS group were found to be significantly higher than the overweight/obese PCOS group (p=0.023). There were no significant association between betatrophin and HOMA-IR levels.

Conclusion:Betatrophin was found to be significantly lower in the overweight/obese group than in the normo-weight PCOS group. Since the role of betatrophin in PCOS and insulin resistance has not been sufficiently clarified, it can be said that it is not a good predictor of insulin resistance in PCOS patients.

Project Number

yok

References

  • 1. Kahraman S, Altinova AE, Yalcin MM, Gulbahar O, Arslan B, Akturk M, Cakir N ,Toruner FB. Association of serum betat- rophin with fibroblast growth factor-21 in women with polycys- tic ovary syndrome. Journal of endocrinological investigation. 2018; 41(9), 1069-1074. 2. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz, R. Poly- cystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature reviews endocrinology. 2011; 7(4), 219-231. 3. Li L, Zhang F, Cui J, Shi Y, Xiang J, Wang X et al. Associa- tion of betatrophin with metabolic characteristics in overweight/ obese and lean women with PCOS. Gynecological Endocrino- logy. 2017; 33(3), 238-243.
There are 1 citations in total.

Details

Primary Language Turkish
Subjects Obstetrics and Gynaecology
Journal Section Research Articles
Authors

Rahime Bedir Fındık 0000-0002-6495-5741

Yasemin Taşçı 0000-0002-6612-7042

Hatice Akkaya 0000-0002-9613-1712

Meryem Kuru Pekcan 0000-0002-4144-2900

Tuba Çandar 0000-0002-3922-5915

Gülnur Özakşit 0000-0001-9117-9728

Jale Karakaya 0000-0002-0867-219X

Project Number yok
Publication Date April 1, 2024
Submission Date June 16, 2023
Acceptance Date February 7, 2024
Published in Issue Year 2024 Volume: 21 Issue: 1

Cite

Vancouver Bedir Fındık R, Taşçı Y, Akkaya H, Kuru Pekcan M, Çandar T, Özakşit G, Karakaya J. ZAYIF VE OBEZ PCOS’ DA İNSÜLİN REZİSTANSI VE KAN BETATROFİN DÜZEYLERİ ARASINDAKİ İLİŞKİ. JGON. 2024;21(1):39-46.